Peripheral blood monocyte and T cell subsets in children with specific polysaccharide antibody deficiency (SPAD)

C Otero1, D Díaz2, I Uriarte2

  • 1Immunology Department, IMEX-CONICET-Academia Nacional de Medicina, Buenos Aires, Argentina.

Human Immunology
|November 19, 2015
PubMed

Insights

Specific polysaccharide antibody deficiency (SPAD) involves more than just B cell defects. This study found immune cell alterations in SPAD patients, suggesting a more complex immunodeficiency than previously understood.

Area of Science:

  • Immunology
  • Clinical Medicine

Background:

  • Specific polysaccharide antibody deficiency (SPAD) is an immunodeficiency marked by poor antibody production against encapsulated bacteria like Streptococcus pneumoniae.
  • Previous understanding suggested SPAD primarily involved B cell defects, sufficient to explain recurrent infections.

Purpose of the Study:

  • To investigate if SPAD patients exhibit defects in leukocyte subpopulations beyond B cells.
  • To determine if these additional defects contribute to impaired adaptive immunity against Streptococcus pneumoniae.

Main Methods:

  • Analysis of leukocyte subpopulations in SPAD patients.
  • Flow cytometry to assess monocyte subsets (CD14++ CD16-, CD14++ CD16+) and T cell populations.

Main Results:

  • SPAD patients lack the typical age-related changes in monocyte percentages seen in healthy children.
  • Absence of increased classical monocytes (CD14++ CD16-) and decreased intermediate monocytes (CD14++ CD16+) with age.
  • Observed alterations in T cell populations within SPAD patients.

Conclusions:

  • The immune deficiency in SPAD patients is more complex than previously recognized, extending beyond B cell dysfunction.
  • Defects in monocytes and T cells may contribute to the recurrent infections observed in SPAD.
  • Further research is needed to fully elucidate the multifaceted immune dysregulation in SPAD.